R Squared LTD Heron Therapeutics, Inc. Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, R Squared LTD holds 12,648 shares of HRTX stock, worth $16,695. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,648Holding current value
$16,695% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
188Shares Held
126MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$35.3 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$10.9 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$10.4 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$9.22 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $157M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...